These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12478722)

  • 21. Backup programs in drug discovery.
    Greenlee WJ; Desai M
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):412-3. PubMed ID: 16889224
    [No Abstract]   [Full Text] [Related]  

  • 22. Applying technologies towards safe and effective medicines.
    Roses A
    Biotechniques; 2005 Oct; 39(10 Suppl):S563-4. PubMed ID: 18957037
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of statistical 'design of experiments' methods in drug discovery.
    Tye H
    Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of drugs: advances in determination, prediction and engineering.
    Datta S; Grant DJ
    Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
    [No Abstract]   [Full Text] [Related]  

  • 25. Predicting therapeutic value in the lead optimization phase of drug discovery.
    Kenakin T
    Nat Rev Drug Discov; 2003 Jun; 2(6):429-38. PubMed ID: 12776218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in biocatalytic synthesis of pharmaceutical intermediates.
    Panke S; Wubbolts M
    Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 28. Micellar solubilization of drugs.
    Rangel-Yagui CO; Pessoa A; Tavares LC
    J Pharm Pharm Sci; 2005 Jul; 8(2):147-65. PubMed ID: 16124926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and enzymatic synthesis of 2-(2-carbamoylethyl)- and 2-(2-carboxyethyl)aziridines and their conversion into δ-lactams and γ-lactones.
    Vervisch K; D'hooghe M; Rutjes FP; De Kimpe N
    Org Lett; 2012 Jan; 14(1):106-9. PubMed ID: 22149132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NaI-catalyzed highly regioselective ring-opening [1 + 2] cycloaddition reaction of cyclopropenes with imines: highly stereoselective synthesis of cis-vinylic aziridines.
    Ma S; Zhang J; Lu L; Jin X; Cai Y; Hou H
    Chem Commun (Camb); 2005 Feb; (7):909-11. PubMed ID: 15700078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current product equivalency issues.
    Gerrard TL
    Food Drug Law J; 1995; 50(3):451-3. PubMed ID: 10343011
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemistry of tetrathiomolybdate: aziridine ring opening reactions and facile synthesis of interesting sulfur heterocycles.
    Sureshkumar D; Koutha SM; Chandrasekaran S
    J Am Chem Soc; 2005 Sep; 127(37):12760-1. PubMed ID: 16159244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regioselective synthesis of fluoroalkylated beta-aminophosphorus derivatives and aziridines from phosphorylated oximes and nucleophilic reagents.
    Palacios F; Ochoa de Retana AM; Alonso JM
    J Org Chem; 2006 Aug; 71(16):6141-8. PubMed ID: 16872198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic applications of chiral 2,3-dihydro-4-pyridones.
    Joseph S; Comins DL
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):870-80. PubMed ID: 12478718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic/pharmacodynamic relationships: basic concepts.
    Trocóniz IF
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():125-6. PubMed ID: 12575479
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemistry strategies in early drug discovery: an overview of recent trends.
    Colombo M; Peretto I
    Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric synthesis of 2-(2-pyridyl)aziridines from 2-pyridineimines bearing stereogenic N-alkyl substituents and regioselective opening of the aziridine ring.
    Savoia D; Alvaro G; Di Fabio R; Gualandi A; Fiorelli C
    J Org Chem; 2006 Dec; 71(25):9373-81. PubMed ID: 17137364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aziridines: epoxides' ugly cousins?
    Sweeney JB
    Chem Soc Rev; 2002 Sep; 31(5):247-58. PubMed ID: 12357722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 1-arylmethyl-2-(cyanomethyl)aziridines and their ring transformation into methyl N-(2-cyanocyclopropyl)benzimidates.
    D'hooghe M; Mangelinckx S; Persyn E; Van Brabandt W; De Kimpe N
    J Org Chem; 2006 May; 71(11):4232-6. PubMed ID: 16709066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.